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Abstract
Background: NF-κB is widely involved in lymphoid malignancies; however, the functional roles and specific
transcriptomes of NF-κB dimers with distinct subunit compositions have been unclear.
Methods: Using combined ChIP-sequencing and microarray analyses, we determined the cistromes and target
gene signatures of canonical and non-canonical NF-κB species in Hodgkin lymphoma (HL) cells.
Results: We found that the various NF-κB subunits are recruited to regions with redundant κB motifs in a large
number of genes. Yet canonical and non-canonical NF-κB dimers up- and downregulate gene sets that are both
distinct and overlapping, and are associated with diverse biological functions. p50 and p52 are formed through
NIK-dependent p105 and p100 precursor processing in HL cells and are the predominant DNA binding subunits.
Logistic regression analyses of combinations of the p50, p52, RelA, and RelB subunits in binding regions that have
been assigned to genes they regulate reveal a cross-contribution of p52 and p50 to canonical and non-canonical
transcriptomes. These analyses also indicate that the subunit occupancy pattern of NF-κB binding regions and their
distance from the genes they regulate are determinants of gene activation versus repression. The pathway-specific
signatures of activated and repressed genes distinguish HL from other NF-κB-associated lymphoid malignancies and
inversely correlate with gene expression patterns in normal germinal center B cells, which are presumed to be the
precursors of HL cells.
Conclusions: We provide insights that are relevant for lymphomas with constitutive NF-κB activation and generally
for the decoding of the mechanisms of differential gene regulation through canonical and non-canonical NF-κB
signaling.
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Background
The NF-κB family of transcription factors (TFs) includes
RelA (p65), RelB, c-Rel, and the precursor proteins p105
and p100, which are processed to p50 and p52, respect-
ively. These subunits can form various homo- and het-
erodimers which regulate gene expression by binding to
κB sites in the promoters and enhancers of genes in a
wide range of mammalian cell types. NF-κB activation
can be achieved through the canonical and non-
canonical signaling pathways. The canonical pathway
involves the degradation of small IκB proteins and the
nuclear translocation of p50-RelA. The non-canonical
pathway depends on the activation of NF-κB-inducing
kinase (NIK) and IκB kinase α (IKKα), resulting in the
induction of NF-κB dimers containing p52 and/or RelB
[1–3]. Our recent work, however, has shown that non-
canonical signaling is more complex. Stimulation through
LTβR results in the parallel production of p50 and p52,
and both are important to assure the full range of signal-
induced gene expression [4].
Activated NF-κB plays a major role in cell cycle progres-
sion and survival, immune responses, and development
[5]. To control such a broad range of physiological pro-
cesses, the NF-κB response relies on diverse and complex
mechanisms that guarantee selectivity by limiting the acti-
vation of only subsets of potential NF-κB target genes.
The regulation of selected sets of genes by distinct NF-κB
subunits may depend on chromatin accessibility, differen-
tial expression, dimer formation, differential DNA recog-
nition, and transactivation mechanisms [6]. The diverse
phenotypes of mice that lack single NF-κB subunits imply
that different dimers regulate distinct sets of genes [7].
However, while previous studies have mainly focused on
RelA and c-Rel and revealed considerable redundancy in
gene expression regulation [8], little is known about the
dependence of the expression of specific genes on canon-
ical versus non-canonical NF-κB dimers. Previous chro-
matin immunoprecipitation (ChIP)-based genome-wide
NF-κB analyses have mostly investigated canonical NF-κB
and been focused on RelA [9–11], or analyzed NF-κB sub-
units in B cells expressing LMP1 [12]. Nonetheless, to our
knowledge, the relation between NF-κB cistromes and
subunit-dependent gene regulation has not yet been ex-
plored in systematic global analyses.
Understanding how particular subunit combinations
control target gene expression is especially important for
cancer biology, where the development and maintenance
of various solid tumors and lymphoid malignancies are
driven by NF-κB [13, 14]. Within B-lymphoid malignan-
cies, constitutive NF-κB activation has been identified in
classical Hodgkin lymphoma (HL) and - to various de-
grees - in non-Hodgkin lymphomas including diffuse
large B-cell lymphoma, mucosa-associated lymphoid tis-
sue lymphoma, primary effusion lymphoma, adult T-cell
lymphoma/leukemia, and multiple myeloma [13, 15].
The deregulation of NF-κB in these malignancies is
caused by diverse mechanisms. Its activation in HL is
thought to be associated with multiple genetic alter-
ations and deregulated autocrine and/or paracrine sig-
naling, leading to constitutive IKK activity [16]. The
presence of activated RelA and of NIK in primary HL
biopsies as well as in HL cell lines [17, 18] indicates a
parallel constitutive activation of canonical and non-
canonical IKK signaling. This makes HL an ideal model
system to study the mechanisms of differential gene
regulation by these two pathways.
Here we dissected the composition of activated NF-κB
subunits, their cistromes, and p50/RelA- and p52/RelB-
specific transcriptomes and functions in HL cells. Our re-
sults revealed that NIK promotes the formation of both
p50 and p52, which account for most NF-κB activity in
HL cells. Major gene expression patterns and cell survival
were dependent on the non-canonical pathway. However,
each of the pathways regulated both unique and overlap-
ping transcriptomes, and these signatures were consistent
with the differential gene expression patterns seen in HL
biopsies. A regression analysis of binding patterns and
regulation indicates a cross-contribution of p50 and p52
to canonical and non-canonical NF-κB pathways. Our
study provides the basis for understanding how canonical
and non-canonical NF-κB pathways regulate gene expres-
sion in tumor cells.
Methods
Cell lines
HL cell lines L428 (ACC 197), L1236 (ACC 530), KM-H2
(ACC 8), L591 (ACC 602), L540 (ACC 72), and HDLM-2
(ACC 17) were purchased from DSMZ (www.dsmz.de).
All cell lines were cultivated in RPMI medium 1640
(Gibco) supplemented with inactivated FBS, according to
the instructions of the provider.
Immunohistochemistry
Immunohistochemical detections of p105/p50 and p100/
p52 were performed as described [19]. A total of 20 bi-
opsies were used, from which 20 samples were stained
for p105/p50 (#3035, Cell Signaling), and 18 were
stained for p100/p52 (HPA008422, Sigma).
Analysis of ChIP-seq data
Short reads from the Illumina sequencer were aligned
using Bowtie, retaining only uniquely mapping reads.
Quality control was performed according to the EN-
CODE guidelines [20]. All our samples passed the strin-
gent QC thresholds (see ‘Quality control of ChIP-seq
libraries’ in Additional file 1: Supplemental Experimental
Procedures). Duplicated reads that are likely to be PCR
artefacts were removed using samtools. In order to be
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able to compare sequencing libraries with different total
read counts we used random sampling to reduce all li-
braries to a size of 10 million reads. The genome wide
distribution of binding regions was determined using
MACS [21]. All ChIP-seq experiments were conducted
in two biological replicates, so we investigated the repro-
ducibility using the IDR method. After IDR analysis,
reads from biological replicates were merged and jointly
analyzed with MACS. Final peak calls were defined as
regions with IDR <0.05 and MACS false discovery rate
(FDR) <0.05. See also Additional file 1: Supplemental Ex-
perimental Procedures for details about peak calling and
combinatorial analysis of NF-κB subunits.
Analysis of gene expression data
Experiments for the knockdown of the two subunit com-
binations (RelA/p50 and RelB/p52) were performed and
analyzed independently. Each experiment was performed
in three biological replicates. For Experiment #1, each
biological replicate was composed of four samples (sam-
ple 1 = siControl #1; sample 2 = siControl#2; sample 3 =
siRELA #1 + siNFKB1 #1; sample 4 = siRELA #2 +
siNFKB1 #2). For Experiment #2, each biological repli-
cate was composed of an additional four samples (sam-
ple 5 = siControl #1; sample 6 = siControl#2; sample 7 =
siRELB #1 + siNFKB2 #1; sample 8 = siRELB #2 +
siNFKB2 #2). For the data analysis, all 24 samples were
separated into four groups (Group1 = all replicates from
samples 1 and 2, Group 2 = all replicates from samples 3
and 4, Group 3 = all replicates from samples 5 and 6,
and Group 4 = all replicates from samples 7 and 8). Dif-
ferential expression was determined using a two-sample
t-test and P values adjusted for multiple testing using
the Benjamini–Hochberg method. A gene was called dif-
ferentially expressed if at least one transcript cluster
assigned to the gene was called differential (FDR <0.05)
and showed at least 10 % expression difference between
Groups 1 and 2 or 3 and 4. See Additional file 1: Supple-
mental Experimental Procedures for details.
Integration of target genes with gene expression in
human lymphomas
Human lymphoma gene expression data were obtained
from GEO (GSE12453). Genes with low average expres-
sion (Affymetrix hybridization signal <6) were removed.
Differential expression was determined between HL and
all remaining samples using the same method as de-
scribed above. For details see Additional file 1.
Results
Predominance of p50 and p52 and non-canonical IKK sig-
naling in the constitutive NF-κB activity in HL
To test the relative contribution of canonical and non-
canonical NF-κB dimers in HL cells, we depleted NIK, a
central component of non-canonical NF-κB signaling.
Notably, NIK depletion not only affected processing of
p100 but also of p105 (Fig. 1a). Ablation of NIK caused
a severe reduction of C-terminal p100 and p105 phos-
phorylation, accumulation of the precursors, and de-
creased generation of their products p52 and p50
(Fig. 1a). This is similar to the NIK-dependent coupled
generation of p50 and p52 that we recently demon-
strated for non-canonical LTβ signaling in fibroblasts
[4]. The p50 and p52 subunits are pivotal to the total
constitutive NF-κB activity in HL cells, since RNA-
mediated knockdown (KD) of both NFKB1 (encoding
p105/p50) and NFKB2 (p100/p52) strongly affected glo-
bal NF-κB DNA-binding, while depletion of the single
NF-κB subunits, including RelA and RelB, did not
(Fig. 1a). Consistent with its role in p50 and p52 produc-
tion, NIK depletion had a similar effect on total NF-κB
DNA-binding (Additional file 2: Figure S1A). Of note, in
addition to slower migrating heteromeric species in the
DNA binding assays, abundant activity migrated at the
position of p50 and p52 dimers (Fig. 1a).
We next investigated the cytoplasmic-nuclear distribu-
tion of the NF-κB subunits in various HL cell lines
(Fig. 1b). A significant fraction of p50 and p52 but only
a low amount of RelA was present in the nucleus. Nu-
clear RelB was ubiquitously detected with variable inten-
sities, whereas differing concentrations of nuclear c-Rel
were observed throughout the cell lines. To evaluate the
canonical and non-canonical NF-κB dimer composition,
p50 and p52 were immunoprecipitated from nuclear ex-
tracts (Additional file 2: Figure S1C). We could readily
detect p52-RelB and to a lesser extent p50-RelB dimers
in all cell lines. However, p50-RelA dimers were present
at variable lower amounts, and p50-c-Rel dimers were
only abundant in L428 and KM-H2 cells, correlating
with their generally restricted nuclear abundance. Fur-
thermore, p50-p52 heterodimers were detected.
Nuclear enrichment of p50 and p52 was also evident in
primary HL samples. A prominent nuclear staining was
seen in 60 % of patients for p50 and in 83 % for p52
(Fig. 1c and Additional file 3: Table S1). Since the N-
terminal epitope-directed antibodies recognize cytoplas-
mic precursors and the products, an excess of nuclear p50
and p52 is indicated in these cells. Altogether, these results
demonstrate that non-canonical, NIK-driven IKK signal-
ing predominantly accounts for constitutive NF-κB activ-
ity in HL cells, which is strongly dominated by production
of dimers that contain p50 or p52. Compared to this, ca-
nonical p50-RelA heterodimers are under-represented.
Constitutive activation of canonical and non-canonical
NF-κB species generates largely overlapping cistromes
To investigate selective functional roles of the RelA, RelB,
p50, and p52 subunits and of the prototypic p50-RelA and
de Oliveira et al. Genome Medicine  (2016) 8:28 Page 3 of 16
p52-RelB heterodimers in the gene expression repertoire
of HL cells, we first performed ChIP-seq analyses of the
four subunits to determine the genome wide distribution
of their binding sites. This should also reveal if distinct
regions and sequences are preferentially bound by canon-
ical and non-canonical NF-κB species. The number of
enriched regions greatly varied, up to 20-fold comparing
RelA and p50 (Additional file 2: Figure S2A and Additional
file 4: Table S2), reflecting the relative nuclear amounts of
the respective NF-κB subunit (Fig. 1b). For each of the
NF-κB datasets individual regions were selected and vali-
dated by qPCR (Additional file 2: Figure S2B). In each
dataset the maximum frequency of ChIP-seq regions was
observed around the TSS (Additional file 2: Figure S2C).
The genomic locations of ChIP-seq regions in relation to
annotated genes are representatively shown for p52 and
p50. About half of the regions were located within tran-
scribed gene regions, with a high percentage within in-
trons (Additional file 2: Figure S2E).
Comparison of the cistromes obtained for the single
NF-κB subunits revealed multiple intersections (Fig. 2a).
RelA shares more than 94 % and RelB more than 85 % of
their ChIP-seq regions with at least one other NF-κB sub-
unit. Binding regions for p50 and p52 overlapped by about
70 %. Remarkably, a large fraction (41 %) of binding re-
gions recruits p50 or p52 alone. Occupancy profiling re-
veals that combinatorial NF-κB subunit recruitment can
be grouped into eight clusters (Fig. 2b) with a most
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Fig. 1 Dominant contribution of p50 and p52 in the constitutive NF-κB activity in HL cells. a Left: RNAi-mediated knockdown (KD) of NIK
(MAP3K14). L1236 cells were incubated with siRNA against MAP3K14 and harvested 1 day after the end of the siRNA treatment. Protein levels of
the precursor proteins p105 and p100, their products p50 and p52, as well as phospho-Ser-866/870-p100 and phospho-Ser-933-p105 were
analyzed in whole extracts by western blot (WB). CDK4 was used as loading control. Right: EMSA analysis of L1236 whole cell extracts after KDs of
single NF-κB subunits and double KD of p50 and p52. Control of KD efficiencies is shown in Additional file 2: Figure S1B. b WB analysis of nuclear
(N) and cytoplasmic (C) distribution of NF-κB subunits in HL cell lines, as indicated (top labels). p105 and PARP1 serve as purity controls for nuclear
and cytoplasmic extracts, respectively. c Immunohistochemical detection of p105/p50 and p100/p52 in representative biopsies from HL patients.
Arrows indicate nuclear abundance of p50 (left panel) and p52 (right panel) in malignant Reed-Sternberg cells compared to surrounding benign
cells. A total of 20 biopsies were used, all were stained for p105/p50 and 18 biopsies were stained for p100/p52
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prominent contribution of p50 and p52, either alone or in
combination. Interestingly, RelB is most frequently seen in
combination with p50 and p52, rather than with p52
alone, while RelA occupancy is least frequent. In many
cases the tag pattern for all NF-κB subunits is very similar
and binding regions are shared, even though the enrich-
ment for RelA is weaker than that for p50, p52 and RelB
(for example, NFKBIA gene). In other cases, the tag pat-
terns differ and only subsets of subunits are present in se-
lected ChIP-seq regions (CDH1 gene, Fig. 2c).
Redundancy in DNA binding was also indicated by de
novo motif searches using MEME [22] with the ChIP-
seq datasets for the different NF-κB subunits. In all data-
sets, an NF-κB motif that resembled the known JASPAR
database entries (MA0101; MA0107; MA0105) was
found with very high frequency (Fig. 3a and b). To assess
whether p50 and p52 dimers recognize distinct DNA
motifs, MEME de novo search was performed with
ChIP-seq regions that selectively recruited p50 or p52.
Again, the NF-κB motifs found for each factor (Additional
file 2: Figure S3) did not grossly differ from motifs found
within regions that recruit more than one subunit (Fig. 3b).
However, p50-selective motifs contained a higher conserva-
tion of a G in the first position compared to p52-selective
motifs, indicating a putative contribution of highly symmet-
ric binding sites for p50 homodimer recruitment.
We next searched for co-occurring binding sites of
potential cooperating TFs within the subunit-specific
ChIP-seq regions. Apart from the expected, statistically
significant occurrence of the NF-κB motif in all datasets,
we found an enrichment of AP-1, IRF, ETS, FOX, and
CTCF motifs (Additional file 5: Table S3). This is in agree-
ment with our finding that protein-occupied AP-1 and
IRF motifs occur closely spaced to NF-κB motifs in global
Fig. 2 ChIP-sequencing analysis of genome wide distribution of RelA, RelB, p50, and p52 binding regions. a Venn diagram showing the total
number and intersections of ChIP-seq regions for p50, p52, RelA, and RelB in L1236 cells. See Additional file 4: Table S2 and Additional file 2:
Figure S2A for ChIP-seq data and gene assignments. b Genome-wide NF-κB subunit occupancy profiles. Left: Regions (peak summit + -500 bp)
were grouped based on their profiles of ChIP enrichment over input for all four subunits using k-means clustering (k = 8). Gray bars on top
indicate the ChIPed subunit. Each row represents a region that was identified as a peak for at least one of the four subunits. The distinct clusters
are indicated by numbers on the left. Right: Regions were also classified by the combination of subunits based on the peak calling results. Gray
bars on top indicate which combination of subunits was called. The color-coded heatmap shows the percentage of regions in each cluster with
a specific combination of subunits. c Visualization of representative ChIP-seq regions (UCSC genome browser). Top, NFKBIA gene with overlapping
peaks for p50, p52, RelA, and RelB in the promoter and first intron. Bottom, intron 2 of the CDH1 gene showing selective binding of p50 and p52
to two ChIP-seq regions
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DNAse I hypersensitive site (DHS) mapping in HL cells
[19]. Furthermore, we showed before that constitutively
activated AP-1 and IRF5 in HL cells functionally synergize
with NF-κB [19, 23].
The cistromes of NF-κB subunits in HL cells differ sig-
nificantly from the binding landscapes previously re-
ported for EBV-transformed lymphoblastoid B cells
(LCL), where the membrane protein LMP1 constitutively
activates the canonical and non-canonical NF-κB path-
ways [12]. In particular, the relative recruitment of RelA
and RelB is notably less in HL cells compared to LCLs,
while p50 and p52 are prevalent in HL cells. The ChIP
regions of NF-κB subunits in HL cells overlap with those
in LCL in average by 54 % (Additional file 6: Table S4).
The binding regions that overlap in both cell types are
summarized in Additional file 7: Table S5.
We also compared the combinatorial binding pattern
of NF-κB subunits in ChIP-seq regions between HL and
LCL (Additional file 8: Table S6). Both cell types strongly
differed in combinatorial subunit binding, roughly in ac-
cordance with the differences in frequencies of subunit
recruitment noted above. Interestingly, patterns exclu-
sively containing the prototypic heterodimers p50-RelA
or p52-RelB are rare in both cell types, about 2 %. The
most frequent subunit combinations in HL cells contain
p50 and/or p52, in contrast to RelA and RelB in LCL.
Furthermore, as expected, the cistromes of the NF-κB
species in HL cells and the DHS sites that we mapped in
these cells [19] largely overlapped. Similarly, binding re-
gions and DHS sites reveal an equivalent extent of over-
lap in LCL (Additional file 6: Table S4).
Thus, globally, the different NF-κB subunit recruit-
ment in HL and LCL cells is in part dictated by the only
partially overlapping open chromatin landscape of the
two cell types.
Distinct biological processes are differentially associated
with genes that are up- or downregulated by p50/RelA
and p52/RelB
To determine the transcriptomes regulated by canonical
and/or non-canonical NF-κB dimers, we depleted the
subunit combinations p50/RelA and p52/RelB (Additional
file 2: Figure S4A). Concentrations of siRNAs and treat-
ment time schedules were optimized for each NF-κB sub-
unit for efficient depletion (Additional file 2: Figure S4B).
Samples were collected 1 day after the end of the respect-
ive siRNA treatments and one day before the initial onset
of apoptosis. We performed global microarray expression
analyses and determined direct targets by matching gene
regulation with ChIP-seq binding data (Additional file 9:
Table S7). Almost fivefold more genes were regulated by
p52/RelB than by p50/RelA. While the majority of genes
were transcriptionally activated, surprisingly, 22 % of p50/
RelA and 36 % of p52/RelB regulated genes were down-
regulated (Fig. 4a and b, top panels, Additional file 9:
Table S7).
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Fig. 3 MEME de novo motif analysis revealed redundant consensus sites for each NF-κB subunit. a Occurrence of de novo detected NF-κB-like
motifs in the indicated numbers of ChIP-seq regions analyzed by MEME. b NF-κB motifs detected by MEME de novo search in each of the four
NF-κB subunit datasets of L1236 cells. See Additional file 5: Table S3 for CLOVER motif analysis data
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Fig. 4 (See legend on next page.)
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Alterations of gene regulation could have been caused
indirectly by depletion of p100 and p105, which can se-
quester other NF-κB subunits in the cytoplasm and con-
sequent liberation of bound Rel factors. However, no
change in the nuclear patterns of RelA, RelB, or c-Rel
was observed (Additional file 2: Figure S4C), suggest-
ing that the altered expression of genes is a direct
consequence of the KD of NF-κB subunits and not of
a loss of the IκB function of the precursors.
For up- and for downregulated genes, the p50/RelA-
and p52/RelB-dependent sets in each case partially over-
lapped, but also revealed genes that were only controlled
by either p50/RelA or p52/RelB (Fig. 4a and b, top
panels). These datasets contained a considerable number
of novel direct NF-κB targets, but also previously known
NF-κB target genes, as expected (Additional file 9:
Table S7). A number of genes that are differentially up- or
downregulated by p50/RelA- and/or p52/RelB have a high
biological significance for HL (for a selection, see Fig. 4c)
and encode cytokines and chemokines responsible for
clinical symptoms and TF networks implicated in this
disease [16].
We next categorized genes directly regulated by p50/
RelA and/or p52/RelB according to their activation or
repression status and grouped them by related biological
processes, using Gene Ontology (GO) terms. The set of
genes upregulated by p50/RelA was predominantly
enriched in immune system processes. These genes are
also important for cell activation, cell communication,
and regulation of programmed cell death. The set of
genes upregulated by p52/RelB is also enriched in these
categories, however, covering a broader spectrum of bio-
logical functions. The cell death categories are shared by
both subunit combinations (Fig. 4a) and include known
NF-κB induced anti-apoptotic genes such as CFLAR and
BCL2L1 (Additional file 9: Table S7).
The gene sets that were downregulated by p50/RelA
or p52/RelB (Additional file 9: Table S7) differed greatly
in the enriched GO terms (Fig. 4b, Additional file 10:
Table S8). Genes that were selectively downregulated by
p50/RelA, like BCL6, are mainly related to general cellular
developmental and differentiation processes. The genes
exclusively downregulated by p52/RelB on the other hand,
including FOXP1 and LEF1, are highly enriched in terms
such as hematopoietic and lymphoid organ development,
negative regulation of cell adhesion, and positive regula-
tion of cell differentiation (Fig. 4b and c, Additional file 9:
Table S7).
Collectively, these results show that p52/RelB controls
the majority of the NF-κB regulated genes and especially
represses genes involved in differentiation processes.
However, both p50/RelA and p52/RelB control genes that
are involved in modulation of immune system responses
as well as cell survival. Both pathways are differentially
engaged in the regulation of genes with previously docu-
mented high or low expression in HL (Fig. 4c).
Correlation of combinatorial binding patterns of NF-κB
subunits and gene expression regulation
By fitting logistic regression models (see Additional file 1:
Supplemental Experimental Procedures for details) we ana-
lyzed if specific combinations of NF-κB subunits that were
determined within the individual ChIP-seq regions could
be used to predict modes of gene expression regulation by
canonical and non-canonical dimers. The best model pa-
rameters were estimated, also considering the available
L1236-DHS data and the genomic 3D architecture in LCL
[19, 24], as outlined in Additional file 2: Figure S5A. We
found that binding of both, p50 and p52, either alone or in
combination with RelB or RelB plus RelA was significantly
associated with regulation (that is, activation or repression)
of gene expression by canonical and non-canonical dimers.
Specifically, the genes regulated by p52/RelB revealed a
high preference for binding of p50 along with p52, with or
without RelB and were independent of proximal or distal
localization of the region relative to the TSS (Fig. 5a).
Genes sensitive to p50/RelA knockdown also revealed the
same preference for p50/p52/RelB but the most significant
subunit combination was p50/p52/RelA/RelB (Fig. 5a). In
this case all regions were restricted to proximal positions.
Likewise, proximal binding of all four subunits, thus in-
cluding RelA, was highly predictive for genes regulated by
canonical compared to non-canonical dimers (Additional
file 2: Figure S5B). Furthermore, we identified the preferen-
tial NF-κB subunit combinations associated with gene acti-
vation or repression. p50/p52/RelB and p50/p52/RelA/
RelB were significantly associated with activated genes
(Additional file 2: Figure S5C). Interestingly, although with
(See figure on previous page.)
Fig. 4 Enriched biological processes and genes with significance for HL biology controlled by p50/RelA and p52/RelB. a, b Genes activated (a) or
repressed (b) by p50/RelA or p52/RelB in L1236 cells, respectively, and functional enrichment analysis of using Gene Ontology for biological
processes (GO) analysis. Top panels: Venn diagrams displaying numbers of total, unique, and overlapping target genes for the two dimer
combinations used for GO analysis (solid and stippled arrows, respectively). Direct target genes of p50/RelA and p52/RelB were defined as bound
by at least p50 and p52, respectively, by ChIP-sequencing and differentially regulated upon KD of the specific dimers (FDR <0.05), and at least
10 % expression difference between the knockdown and control experiment). See Additional file 10: Table S8 for GO analysis data. c Schematic
representation of canonical and non-canonical target genes that are known to be relevant for HL biology. Among both up- and downregulated
genes, two functional groups were highly represented in HL literature: (1) cytokines and receptors, and (2) components of NF-κB-subordinated
pathways [16, 19, 29, 50]
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lesser confidence, binding of p50/p52 scored highest with
repressed genes when in distal positions, but with ac-
tivation, when at proximal positions (Additional file 2:
Figure S5C and D). The compositional and positional cor-
relation of NF-κB subunit binding pattern with gene acti-
vation and repression is schematically summarized in
Fig. 5b. With exception of p50/p52 (binary code ‘1100’ in
Fig. 5a), the identified high confidence binding patterns
did not simply correlate with their frequency of occurrence
in the ChIP-seq datasets (Additional file 8: Table S6).
Importantly, exclusive recruitment of prototypic dimers
(p50-RelA or p52-RelB) was not significantly associated
with gene regulation (‘1010’ and ‘0101’ in Fig. 5a and
Additional file 2: Figures S5B and C).
Taken together, the logistic regression analyses reveal
that the specificity of NF-κB subunit-selective gene
regulation is not determined by the exclusive recruit-
ment of the targeted prototypic dimers, but by more
complex combinations of NF-κB subunits, involving a
parallel contribution of p50 and p52. The most active
combinations (1111, 1101, and 1100) are part of clusters
C4 and C8 (Fig. 2b), revealing strongest and equal p50
and p52 recruitment.
Cell survival of HL cells is predominantly controlled by
the non-canonical NF-κB pathway
We next investigated the relative impact of p50-RelA
and p52-RelB, both of which activated genes associated
with cell death/apoptosis (Fig. 4a), on cell viability. Close
monitoring of siRNA-treated HL cells revealed a 30 % to
40 % decrease of cell viability upon p50/RelA KD and up
to 95 % reduction in viability upon p52/RelB KD (Fig. 6a
Fig. 5 Prediction of gene expression patterns from combinatorial binding of NF-κB subunits using logistic regression analyses. a Left: Regulation
by non-canonical NF-κB versus no regulation. Right: Regulation by canonical NF-κB versus no regulation. Note that both, up- and downregulated
genes are included in the categories ‘canonical’ regulated or ‘non-canonical’ regulated genes. Different parameter choices were systematically
analyzed to evaluate the performance of the prediction framework for the logistic regression models (see Additional file 2: Figure S5). The y-axis
shows the combinations of NF-κB subunits, which are listed as binary vectors (1 = presence, 0 = absence). The x-axis shows parameter estimates
of the logistic regression models, which can be interpreted as log odds ratios and are indicated by circles. Vertical lines show confidence intervals
(95 %). Filled circles indicate that parameters are significantly different from zero (P <0.01). Missing estimates and confidence intervals occur when
the specific subunit combination was not observed in the dataset. Bar plots on the right side indicate the percentage of bootstrap samples in
which each parameter was significantly different from zero (P <0.01). The dashed line marks 90 %. See Additional file 1: Supplemental Experimental
Procedures for details. b Schematic presentation of the dependency of gene activation or repression on the distance and subunit occupancies of
NF-κB binding regions
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and Additional file 2: Figures S6A and B). The cleavage
of initiator caspases 8 and 9, indicating apoptosis, were
predominantly increased upon KD of non-canonical and
canonical subunits, respectively, while effector caspase 3
was equally activated in both groups (Fig. 6b). Interest-
ingly, we observed a correlation between the activation
of initiator caspases and the protein amounts of negative
regulators of apoptosis such as c-FLIP and Bcl- XL
(Fig. 6b). c-FLIP downregulation sensitizes HL cells to
death receptor-induced apoptosis [25]. CFLAR mRNA
expression was downregulated by the KD of both
combinations of NF-κB subunits, but a decrease in pro-
tein levels was only observed upon the KD of p52/RelB,
which was concomitant to strong caspase 8 activation
(see Fig. 6b). Overexpression of Bcl-XL blocks the intrin-
sic apoptosis pathway in many cell types [26, 27] and its
protein level was downregulated by the KD of p52/RelB
as well as of p50/RelA (Fig. 6b). To investigate the pos-
sible connection between the downregulation of Bcl-XL
caused by the KD of NF-κB dimers and apoptosis, we
tested the effect of BCL2L1 knockdown. Following this,
we observed an up to 30 % decrease in cell viability in
a
b
Active caspase 8 (p18)
Active caspase 9 (p10)
Active caspase 3 (p17)
-tubulin
Bcl-XL
c-FLIPS/L
RelA
RelB
p52
p50
Fig. 6 Non-canonical as well as canonical subunits inhibit apoptosis of HL cells. a HL cell lines (L1236, L540 and KM-H2) were treated with two
distinct siRNA sequences against p50/RelA and p52/RelB, as indicated and harvested 3 days after the end of the siRNA treatments. Overall redox
activity of the cells was measured using Alamar Blue assay. Error bars represent SEM (n = 3). See Additional file 2: Figures S6A and B for time-
course experiments. For time-course experiments see Additional file 2: Figures S6A and B. b WB analysis of p50/RelA or p52/RelB KD efficiencies
and expression of the initiator caspase 8 (p18), the initiator caspase 9 (p10), and the effector caspase 3 (p17) in the samples of L1236 cells treated
with siRNAs as described above. Protein levels of the two apoptosis inhibitors (c-FLIPS/L and Bcl-XL) identified as NF-κB target genes are also
shown. α-tubulin was used as loading control
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HL cell lines, along with activation of caspases 9 and 3
(Additional file 2: Figure S6C and D). This suggests that
Bcl-XL blocks the activation of the intrinsic apoptosis
pathway in HL cells and is partially responsible for the
NF-κB-dependent control of HL cell survival.
Taken together, our results indicate that the activa-
tion of p52-RelB is essential for the survival of HL
cells through the upregulation of proteins that block
the intrinsic and especially the extrinsic apoptosis
pathway (for example, c-Flip), whereas p50-RelA also
contributes to survival by the upregulation of Bcl-XL
and subsequent inhibition of the intrinsic apoptosis
pathway.
p50-RelA and p52-RelB gene signatures distinguish
classical Hodgkin lymphoma from other lymphomas and
normal B cells
In order to compare the gene sets regulated by the p50/
RelA and p52/RelB subunit combinations, reflecting ca-
nonical and non-canonical NF-κB signaling in HL cells
in vitro, with primary human lymphoma, we performed
a retrospective analysis of microarray datasets generated
from micro-dissected Hodgkin/Reed Sternberg (HRS)
cells of classical HL, other malignant B cell lymphomas,
and normal B cells at various stages of differentiation
[28, 29]. We identified 123 genes that were direct NF-κB
targets in L1236 cells and differentially regulated in pri-
mary HRS cells when compared to other malignant and
normal B cells (Fig. 7; Additional file 11: Table S9).
These genes were classified into three groups, genes
regulated by canonical, non-canonical, or both NF-κB
pathways. Selected examples of regulated genes were
validated by RT-qPCR (Additional file 2: Figure S7).
Some genes that were activated by NF-κB in L1236
cells and identified as classical HL signatures were also
upregulated in other B-cell lymphomas, where NF-κB
activation has been observed previously, such as nodular
lymphocyte-predominant HL (NLPHL) [28], T cell-rich
B cell lymphoma (TCRBL) [28] and DLBCL [30] (Fig. 7).
These genes were downregulated in normal B cells and
also in Burkitt’s lymphoma (BL), where NF-κB is not ac-
tivated [31, 32].
Interestingly, genes that were repressed in L1236 by NF-
κB and downregulated in classical HL, were upregulated
in normal germinal center (GC) B cells (centroblasts and
centrocytes) (Fig. 7). Thus, NF-κB might contribute to the
characteristic de-differentiation of HL cells, which are de-
rived from germinal center B cells [16].
Our results show that gene sets that are differentially
up- or downregulated by canonical and non-canonical
NF-κB signaling in L1236 cells, which were used as a
model system, are differentially expressed in a similar
manner in primary HL tumor cells compared to other B
cell malignancies.
Discussion
In various lymphoid malignancies, oncogenic constitu-
tive NF-κB activity is determined to varying extents by
canonical and non-canonical signaling, as indicated by
mutations in upstream pathway components [13]. How-
ever, the specific contributions of constitutive canonical
versus non-canonical NF-κB species to cancer biology
remain poorly understood. Here, we analyzed the gen-
omic landscapes of p50, p52, RelA, and RelB in HL cells
by ChIP-sequencing and combined these data with the
genes regulated by these subunits.
We could demonstrate that NF-κB dependent gene ex-
pression in HL cells is largely driven by the non-
canonical pathway. The central kinase of this pathway,
NIK, is known to be overexpressed in HL cell lines and
primary cells [18, 33]. We show that NIK triggers not
only p100, but also p105 precursor processing to p52
and p50. This finding is consistent with NIK-dependent
processing of both precursors in LTβ-stimulated cells,
which we have recently characterized [4]. We also noted
a surprisingly low translocation of RelA. Interestingly,
low levels of nuclear translocation/activation of RelA
and the parallel increase of p50 and p52 in HL cells can
be observed at late time points upon stimulation with
TWEAK or CD40 [34, 35], suggesting that this might be
a common feature of cells with stimulated NIK path-
ways. A similar pattern is also seen in peripheral T cell
lymphoma [36] and multiple myeloma [37].
Constitutive non-canonical signaling causes abundant
nuclear activities of p50 and p52 and each of them is
recruited to more than 10,000 binding regions. This
number of binding regions for NF-κB subunits in HL
cells is comparable to the number determined in
prior studies using lymphoblastoid B cells [10, 12].
However, we show that only a small fraction of these
genes are transcriptionally regulated. In addition, we
observed a lower contribution of RelA recruitment
and of p50-RelA to the control of NF-κB dependent
gene expression.
We asked for non-redundant functions, that is, a func-
tional ‘addictiveness’ of regulated genes to particular
subunit combinations by knocking down p50/RelA or
p52/RelB. Several established NF-κB targets, which were
previously identified [38], such as CCR7, CCND2, FAS,
JUNB, or VCAM1, were bound by canonical and non-
canonical subunits, but not regulated upon knockdown.
This fact can be explained by redundant functions of
NF-κB subunits or the applied stringency of the parame-
ters used in our gene expression analysis. From a total of
501 activated genes, 63 were activated by both, p50/RelA
and p52/RelB, revealing additive or synergistic regu-
lation. This group of target genes comprised BIRC2
(encoding cIAP1), BCL2L1 (Bcl-XL), CFLAR (c-FLIP),
CD40, IRF5, STAT5A, CSF2, CCL22, and HEY1, all of
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Fig. 7 (See legend on next page.)
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which are known to be expressed at high levels in HL
cells [19, 38, 39].
Surprisingly, one-third of all genes regulated by NF-
κB were suppressed. The observed suppression of
genes by both dimer combinations may be caused by
subunit exchange mechanisms. p50 or p52 dimers
that lack transactivation domains and do not interact
with transcriptional co-activators, may prevent access
of activating RelA or RelB containing heterodimers.
Furthermore, p50 and p52 may recruit repressor com-
plexes, including histone deacetylases [1, 40, 41], in a
context-dependent manner to suppress transcription.
Indeed, our logistic regression models indicate that a
combined recruitment of p50 and p52 significantly
correlated with gene expression.
In addition to the separate biological processes identi-
fied by GO analyses for canonical and non-canonical
subunit combinations, overlapping functions were impli-
cated in cell death regulation. Indeed, we were able to
demonstrate that apoptosis was most prominently inhib-
ited by p52/RelB that primarily affected the extrinsic
apoptosis pathway, while p50/RelA contributed to cell
death protection by interfering with the intrinsic path-
way. Thus, HL cells engage in both apoptosis pathways
to block cell death, which is similar to mature murine B
cells, where both are essential for maintenance and in
part are interchangeable [42].
Another interesting observation was the fact that
genes downregulated by NF-κB in HL cells were upregu-
lated in normal germinal center (GC) B cells (Fig. 7).
Among these genes were BCL6 and PAX5 as well as
other important regulators of B cell development, such
as FOXP1 [43], JAK1 [44], and PTPN6 [45], suggesting
that NF-κB signaling may contribute to the known de-
differentiation process of HL cells, which are derived
from GC cells [16]. Activation of the canonical NF-κB
subunits is important for the maintenance and differenti-
ation of GC B cells [46], but the role of the non-canonical
subunits in this stage of the B-cell development remains
unclear. Our signatures of suppressed genes will thus
be an interesting source for future studies of HL
lymphomagenesis.
We also show that the differential gene regulation pro-
grams of canonical and non-canonical NF-κBs were
neither explainable by differences in their DNA se-
quence elements, nor by exclusive recruitment of dimer
species to the genes they regulate. The MEME analysis
of the ChIP-seq datasets for the different NF-κB sub-
units revealed high redundancy in the conserved motifs.
Not taking into account a very weak first position in mo-
tifs related to p50, p52, and RelB, we have found in this
study very similar 11-bp motifs for each factor (p50, p52,
RelA, and RelB). Yet, we could notice a more specific C
at the final position for p50 and p52. A similar redun-
dancy of motifs was also found in the recruitment pat-
terns in lymphoblastoid cells [12].
The motifs found, for example, in regions selective for
p50 or p52 did not considerably differ from those associ-
ated with additional binding of RelA or RelB, which indi-
cates that other constraints such as protein-protein
interactions are important in determining recruitment.
Accordingly, the differential interaction of NF-κB with
other TFs may establish functional gene selectivity. Mo-
tifs for bZIP, ETS, FOX, IRF and CTCF families were sig-
nificantly over-represented in binding regions of all four
NF-κB subunits. Interestingly, these motifs belong to a
dense cluster of TF binding sites surrounding cohesin
anchor sites, which may contribute to the regulation of
nearby genes [47]. Indeed, we have shown before that
AP1 and IRF5, which are recruited to bZIP and IRF mo-
tifs, functionally synergize with NF-κB [19, 23]. This syn-
ergism may control chromatin accessibility, as was
shown for AP1 in other systems [48, 49].
It remains a difficult task to correlate binding of a
given subunit to an individual gene with the regulation
of this gene, since regulation may be conferred by other
remote regions. We therefore developed logistic regres-
sion models to dissect the overall correlation between
transcriptional regulation and recruitment of combina-
tions of NF-κB subunits. This analysis provided insight
into the functional subunit organization, such as a cross-
contribution of p50 to gene regulation by non-canonical
p52-containing dimers and vice versa. It ruled out that
exclusive recruitment of the prototypic dimers p50-RelA
and p52-RelB alone is significantly associated with gene
regulation. This analysis also clearly indicated that RelA-
containing binding patterns correlated with function
only from proximal, but not distal localizations, while
(See figure on previous page.)
Fig. 7 Canonical and non-canonical NF-κB target genes differentiate primary HL from other lymphoid malignancies. The canonical and non-
canonical NF-κB signatures identified in L1236 cells were evaluated using public gene expression data from patient samples (normal and
malignant B cells [28]) available in GEO (GSE12453), by comparing their expression in HL samples to the rest. The heat map expression levels are
encoded by the base 2 logarithmic scale color bar (right). A total of 123 NF-κB regulated genes were differentially expressed in HL samples and
presented concordant expression changes (activation by NF-κB dimers and upregulation in HL samples or repression by NF-κB dimers and down-
regulation in HL samples). The gene names (left) and lymphoid cell types (top) are indicated. BL, Burkitt’s lymphoma; DLBCL, diffuse large B-cell
lymphoma; FL, follicular lymphoma; NLPHL, nodular lymphocyte-predominant HL; TCRBL, T cell-rich B cell lymphoma. Germinal center (GC) B cells
are indicated (bottom). See also Additional file 11: Table S9
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p50, p52, and RelB were distance independent. Conse-
quently, the distinct NF-κB species do have different
preferences for action through enhancers or other re-
mote positions versus promoters. Thus, the models de-
veloped here using binary codes for NF-κB subunits
allowed us to correlate gene expression regulation with
specific combinatorial subunit occupancy.
Conclusions
In summary, in this study we have dissected the NF-κB
subunit dependent gene expression pattern in HL cells,
providing datasets that will be the basis for future com-
parative analyses once equivalent functional investigations
for other NF-κB-associated malignancies become avail-
able. The understanding of the differential contributions
of canonical and non-canonical NF-κB species to tran-
scriptional networks and of their potential synergisms of
action on targets will be crucial for establishing refined
functional gene signatures. The latter may provide import-
ant information for future stratification of NF-κB associ-
ated malignancies and for the evaluation of novel NF-κB
pathway directed drugs for individualized therapies.
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